Cargando…

Complement-dependent mpox-virus-neutralizing antibodies in infected and vaccinated individuals

Mpox virus (MPXV) caused a multi-country outbreak in non-endemic areas in 2022. Following historic success of smallpox vaccination with vaccinia virus (VACV)-based vaccines, the third generation modified vaccinia Ankara (MVA)-based vaccine was used as prophylaxis for MPXV, but its effectiveness rema...

Descripción completa

Detalles Bibliográficos
Autores principales: Hubert, Mathieu, Guivel-Benhassine, Florence, Bruel, Timothée, Porrot, Françoise, Planas, Delphine, Vanhomwegen, Jessica, Wiedemann, Aurélie, Burrel, Sonia, Marot, Stéphane, Palich, Romain, Monsel, Gentiane, Diombera, Harouna, Gallien, Sébastien, Lopez-Zaragoza, Jose Luis, Vindrios, William, Taieb, Fabien, Fernandes-Pellerin, Sandrine, Delhaye, Maurine, Laude, Hélène, Arowas, Laurence, Ungeheuer, Marie-Noelle, Hocqueloux, Laurent, Pourcher, Valérie, Prazuck, Thierry, Marcelin, Anne-Geneviève, Lelièvre, Jean-Daniel, Batéjat, Christophe, Lévy, Yves, Manuguerra, Jean-Claude, Schwartz, Olivier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10188274/
https://www.ncbi.nlm.nih.gov/pubmed/37196656
http://dx.doi.org/10.1016/j.chom.2023.05.001
_version_ 1785042879687688192
author Hubert, Mathieu
Guivel-Benhassine, Florence
Bruel, Timothée
Porrot, Françoise
Planas, Delphine
Vanhomwegen, Jessica
Wiedemann, Aurélie
Burrel, Sonia
Marot, Stéphane
Palich, Romain
Monsel, Gentiane
Diombera, Harouna
Gallien, Sébastien
Lopez-Zaragoza, Jose Luis
Vindrios, William
Taieb, Fabien
Fernandes-Pellerin, Sandrine
Delhaye, Maurine
Laude, Hélène
Arowas, Laurence
Ungeheuer, Marie-Noelle
Hocqueloux, Laurent
Pourcher, Valérie
Prazuck, Thierry
Marcelin, Anne-Geneviève
Lelièvre, Jean-Daniel
Batéjat, Christophe
Lévy, Yves
Manuguerra, Jean-Claude
Schwartz, Olivier
author_facet Hubert, Mathieu
Guivel-Benhassine, Florence
Bruel, Timothée
Porrot, Françoise
Planas, Delphine
Vanhomwegen, Jessica
Wiedemann, Aurélie
Burrel, Sonia
Marot, Stéphane
Palich, Romain
Monsel, Gentiane
Diombera, Harouna
Gallien, Sébastien
Lopez-Zaragoza, Jose Luis
Vindrios, William
Taieb, Fabien
Fernandes-Pellerin, Sandrine
Delhaye, Maurine
Laude, Hélène
Arowas, Laurence
Ungeheuer, Marie-Noelle
Hocqueloux, Laurent
Pourcher, Valérie
Prazuck, Thierry
Marcelin, Anne-Geneviève
Lelièvre, Jean-Daniel
Batéjat, Christophe
Lévy, Yves
Manuguerra, Jean-Claude
Schwartz, Olivier
author_sort Hubert, Mathieu
collection PubMed
description Mpox virus (MPXV) caused a multi-country outbreak in non-endemic areas in 2022. Following historic success of smallpox vaccination with vaccinia virus (VACV)-based vaccines, the third generation modified vaccinia Ankara (MVA)-based vaccine was used as prophylaxis for MPXV, but its effectiveness remains poorly characterized. Here, we applied two assays to quantify neutralizing antibodies (NAbs) in sera from control, MPXV-infected, or MVA-vaccinated individuals. Various levels of MVA NAbs were detected after infection, historic smallpox, or recent MVA vaccination. MPXV was minimally sensitive to neutralization. However, addition of complement enhanced detection of responsive individuals and NAb levels. Anti-MVA and -MPXV NAbs were observed in 94% and 82% of infected individuals, respectively, and 92% and 56% of MVA vaccinees, respectively. NAb titers were higher in individuals born before 1980, highlighting the impact of historic smallpox vaccination on humoral immunity. Altogether, our results indicate that MPXV neutralization is complement dependent and uncover mechanisms underlying vaccine effectiveness.
format Online
Article
Text
id pubmed-10188274
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-101882742023-05-17 Complement-dependent mpox-virus-neutralizing antibodies in infected and vaccinated individuals Hubert, Mathieu Guivel-Benhassine, Florence Bruel, Timothée Porrot, Françoise Planas, Delphine Vanhomwegen, Jessica Wiedemann, Aurélie Burrel, Sonia Marot, Stéphane Palich, Romain Monsel, Gentiane Diombera, Harouna Gallien, Sébastien Lopez-Zaragoza, Jose Luis Vindrios, William Taieb, Fabien Fernandes-Pellerin, Sandrine Delhaye, Maurine Laude, Hélène Arowas, Laurence Ungeheuer, Marie-Noelle Hocqueloux, Laurent Pourcher, Valérie Prazuck, Thierry Marcelin, Anne-Geneviève Lelièvre, Jean-Daniel Batéjat, Christophe Lévy, Yves Manuguerra, Jean-Claude Schwartz, Olivier Cell Host Microbe Article Mpox virus (MPXV) caused a multi-country outbreak in non-endemic areas in 2022. Following historic success of smallpox vaccination with vaccinia virus (VACV)-based vaccines, the third generation modified vaccinia Ankara (MVA)-based vaccine was used as prophylaxis for MPXV, but its effectiveness remains poorly characterized. Here, we applied two assays to quantify neutralizing antibodies (NAbs) in sera from control, MPXV-infected, or MVA-vaccinated individuals. Various levels of MVA NAbs were detected after infection, historic smallpox, or recent MVA vaccination. MPXV was minimally sensitive to neutralization. However, addition of complement enhanced detection of responsive individuals and NAb levels. Anti-MVA and -MPXV NAbs were observed in 94% and 82% of infected individuals, respectively, and 92% and 56% of MVA vaccinees, respectively. NAb titers were higher in individuals born before 1980, highlighting the impact of historic smallpox vaccination on humoral immunity. Altogether, our results indicate that MPXV neutralization is complement dependent and uncover mechanisms underlying vaccine effectiveness. Elsevier Inc. 2023-06-14 2023-05-05 /pmc/articles/PMC10188274/ /pubmed/37196656 http://dx.doi.org/10.1016/j.chom.2023.05.001 Text en © 2023 Elsevier Inc. Elsevier has created a Monkeypox Information Center (https://www.elsevier.com/connect/monkeypox-information-center) in response to the declared public health emergency of international concern, with free information in English on the monkeypox virus. The Monkeypox Information Center is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its monkeypox related research that is available on the Monkeypox Information Center - including this research content - immediately available in publicly funded repositories, with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the Monkeypox Information Center remains active.
spellingShingle Article
Hubert, Mathieu
Guivel-Benhassine, Florence
Bruel, Timothée
Porrot, Françoise
Planas, Delphine
Vanhomwegen, Jessica
Wiedemann, Aurélie
Burrel, Sonia
Marot, Stéphane
Palich, Romain
Monsel, Gentiane
Diombera, Harouna
Gallien, Sébastien
Lopez-Zaragoza, Jose Luis
Vindrios, William
Taieb, Fabien
Fernandes-Pellerin, Sandrine
Delhaye, Maurine
Laude, Hélène
Arowas, Laurence
Ungeheuer, Marie-Noelle
Hocqueloux, Laurent
Pourcher, Valérie
Prazuck, Thierry
Marcelin, Anne-Geneviève
Lelièvre, Jean-Daniel
Batéjat, Christophe
Lévy, Yves
Manuguerra, Jean-Claude
Schwartz, Olivier
Complement-dependent mpox-virus-neutralizing antibodies in infected and vaccinated individuals
title Complement-dependent mpox-virus-neutralizing antibodies in infected and vaccinated individuals
title_full Complement-dependent mpox-virus-neutralizing antibodies in infected and vaccinated individuals
title_fullStr Complement-dependent mpox-virus-neutralizing antibodies in infected and vaccinated individuals
title_full_unstemmed Complement-dependent mpox-virus-neutralizing antibodies in infected and vaccinated individuals
title_short Complement-dependent mpox-virus-neutralizing antibodies in infected and vaccinated individuals
title_sort complement-dependent mpox-virus-neutralizing antibodies in infected and vaccinated individuals
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10188274/
https://www.ncbi.nlm.nih.gov/pubmed/37196656
http://dx.doi.org/10.1016/j.chom.2023.05.001
work_keys_str_mv AT hubertmathieu complementdependentmpoxvirusneutralizingantibodiesininfectedandvaccinatedindividuals
AT guivelbenhassineflorence complementdependentmpoxvirusneutralizingantibodiesininfectedandvaccinatedindividuals
AT brueltimothee complementdependentmpoxvirusneutralizingantibodiesininfectedandvaccinatedindividuals
AT porrotfrancoise complementdependentmpoxvirusneutralizingantibodiesininfectedandvaccinatedindividuals
AT planasdelphine complementdependentmpoxvirusneutralizingantibodiesininfectedandvaccinatedindividuals
AT vanhomwegenjessica complementdependentmpoxvirusneutralizingantibodiesininfectedandvaccinatedindividuals
AT wiedemannaurelie complementdependentmpoxvirusneutralizingantibodiesininfectedandvaccinatedindividuals
AT burrelsonia complementdependentmpoxvirusneutralizingantibodiesininfectedandvaccinatedindividuals
AT marotstephane complementdependentmpoxvirusneutralizingantibodiesininfectedandvaccinatedindividuals
AT palichromain complementdependentmpoxvirusneutralizingantibodiesininfectedandvaccinatedindividuals
AT monselgentiane complementdependentmpoxvirusneutralizingantibodiesininfectedandvaccinatedindividuals
AT diomberaharouna complementdependentmpoxvirusneutralizingantibodiesininfectedandvaccinatedindividuals
AT galliensebastien complementdependentmpoxvirusneutralizingantibodiesininfectedandvaccinatedindividuals
AT lopezzaragozajoseluis complementdependentmpoxvirusneutralizingantibodiesininfectedandvaccinatedindividuals
AT vindrioswilliam complementdependentmpoxvirusneutralizingantibodiesininfectedandvaccinatedindividuals
AT taiebfabien complementdependentmpoxvirusneutralizingantibodiesininfectedandvaccinatedindividuals
AT fernandespellerinsandrine complementdependentmpoxvirusneutralizingantibodiesininfectedandvaccinatedindividuals
AT delhayemaurine complementdependentmpoxvirusneutralizingantibodiesininfectedandvaccinatedindividuals
AT laudehelene complementdependentmpoxvirusneutralizingantibodiesininfectedandvaccinatedindividuals
AT arowaslaurence complementdependentmpoxvirusneutralizingantibodiesininfectedandvaccinatedindividuals
AT ungeheuermarienoelle complementdependentmpoxvirusneutralizingantibodiesininfectedandvaccinatedindividuals
AT hocquelouxlaurent complementdependentmpoxvirusneutralizingantibodiesininfectedandvaccinatedindividuals
AT pourchervalerie complementdependentmpoxvirusneutralizingantibodiesininfectedandvaccinatedindividuals
AT prazuckthierry complementdependentmpoxvirusneutralizingantibodiesininfectedandvaccinatedindividuals
AT marcelinannegenevieve complementdependentmpoxvirusneutralizingantibodiesininfectedandvaccinatedindividuals
AT lelievrejeandaniel complementdependentmpoxvirusneutralizingantibodiesininfectedandvaccinatedindividuals
AT batejatchristophe complementdependentmpoxvirusneutralizingantibodiesininfectedandvaccinatedindividuals
AT levyyves complementdependentmpoxvirusneutralizingantibodiesininfectedandvaccinatedindividuals
AT manuguerrajeanclaude complementdependentmpoxvirusneutralizingantibodiesininfectedandvaccinatedindividuals
AT schwartzolivier complementdependentmpoxvirusneutralizingantibodiesininfectedandvaccinatedindividuals